RTF1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.74071868030978E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.9666000000983E-07 |
Normal-vs-Stage2 |
4.436200000002E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.900800E-03 |
Stage1-vs-Stage2 |
7.533000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.093200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.685800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.63087379343597E-12 |
Normal-vs-AfricanAmerican |
2.22340035271884E-10 |
Normal-vs-Asian |
2.592200E-02 |
Caucasian-vs-AfricanAmerican |
5.100500E-03 |
Caucasian-vs-Asian |
9.739200E-01 |
AfricanAmerican-vs-Asian |
1.329850E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.55699999951453E-07 |
Normal-vs-Female |
7.53700000188928E-08 |
Male-vs-Female |
4.164400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.823800E-04 |
Normal-vs-Extreme_Weight |
3.08189999964625E-07 |
Normal-vs-Obese |
9.384500E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.148760E-01 |
Normal_Weight-vs-Obese |
3.728100E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.570400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.688440E-01 |
Normal-vs-Age(41-60Yrs) |
1.026350E-04 |
Normal-vs-Age(61-80Yrs) |
1.44589999973022E-08 |
Normal-vs-Age(81-100Yrs) |
2.743400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.411150E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.092300E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.493400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.314800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.131800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.421600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.748600E-01 |
Normal-vs-Grade 3 |
7.859200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.242800E-01 |
Grade 2-vs-Grade 4 |
8.748600E-01 |
Grade 3-vs-Grade 4 |
7.859200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.2036005525573E-10 |
Normal-vs-N1 |
5.860500E-03 |
N0-vs-N1 |
4.615800E-02 |
|
|